A group of immune proteins called the inflammasome can help prevent blood stem cells from becoming malignant by removing certain receptors from their surfaces and blocking cancer gene activity, ...
As if understanding this complex evolutionary puzzle were not ... Instead of the V(D)JC composition of immunoglobulin-based B cell receptors (BCRs) and T cell receptors (TCRs) in jawed vertebrates ...
Bristol Myers Squibb Canada (BMS) is pleased to announce Health Canada's approval of Breyanzi® (lisocabtagene maraleucel), a type of chimeric antigen receptor T cell (CAR T) therapy, for the treatment ...